Biopharma News

Nov 24, 2014
By BioPharm International Editors
Ulf Wiinberg has resigned as Lundbeck's CEO over unapproved acceptance of shares in a biotech company.
Nov 24, 2014
By BioPharm International Editors
GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.
Nov 24, 2014
The announcement calls attention to another partnership in the growing T-cell receptor engineering space.
Nov 20, 2014
By BioPharm International Editors
The $200-million project will expand Amgen's single-use/disposable manufacturing capabilities.
Nov 17, 2014
The transaction provides Allergan stockholders with immediate value and enhanced commercial opportunities, according to a company statement.
Nov 17, 2014
Avastin plus chemotherapy for the treatment of ovarian cancer increased progression-free survival by 62% compared with chemotherapy alone.
Nov 17, 2014
Pfizer will pay $850 million upfront and as much as $2 billion later in a deal to jointly develop one of Merck?s cancer drugs.
Nov 14, 2014
The new location will increase Bristol-Myers Squibb's biologics manufacturing capacity.
Nov 13, 2014
By BioPharm International Editors
USP releases compendium of quality standards for compounded medicines.
Nov 13, 2014
By BioPharm International Editors
The Alios Biopharma acquisition strengthens J&J's infectious disease pipeline.
native1_300x100
lorem ipsum